China Yct International Group Quick Ratio (CYIG) starting from the third quarter 2018 to third quarter 2017, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
China Yct International Group, Inc.  (CYIG)

China Yct International Group's Quick Ratio

CYIG's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


China Yct International Group's Cash & cash equivalent grew by 12.03 % in the Q3 2018 sequentially, while Current Liabilities decreased, this led to improvement in China Yct International Group's Quick Ratio to 17.15, above China Yct International Group, Inc. average Quick Ratio.

Within Major Pharmaceutical Preparations industry 48 other companies have achieved higher Quick Ratio than China Yct International Group in third quarter 2018. While Quick Ratio total ranking in the third quarter 2018 has deteriorated compared to the prior quarter from 178 to 217.

Explain Quick Ratio?
How much Cash & cash equivalents CYIG´s has?
What are CYIG´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYIG Quick Ratio (Dec 31 2018)
Q3		 (Sep 30 2018)
Q2		 (Jun 30 2018)
Q1		 (Mar 31 2018)
Q4		 (Dec 31 2017)
Q3
Y / Y Current Liabilities Change 60.08 % 60.59 % 0.96 % -33.59 % -13.39 %
Y / Y Cash & cash equivalent Change 84.34 % 61.38 % 79.45 % 129.15 % 107.46 %
Quick Ratio MRQ 17.15 15.2 20.15 13.59 14.9
CYIG's Total Ranking # 217 # 178 # 179 # 216 # 67
Seq. Current Liabilities Change -0.71 % 50.74 % -26.5 % 45.52 % -0.4 %
Seq. Cash & cash equivalent Change 12.03 % 13.71 % 9.02 % 32.73 % -1.93 %



Quick Ratio third quarter 2018 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 49
Healthcare Sector # 76
Overall Market # 217


Quick Ratio Statistics
High Average Low
62.76 14.12 1.68
(Jun 30 2013)   (Sep 30 2015)




Financial Statements
China Yct International Group's Current Liabilities $ 2 Millions Visit CYIG's Balance sheet
China Yct International Group's Cash & cash equivalent $ 37 Millions Visit CYIG's Balance sheet
Source of CYIG's Sales Visit CYIG's Sales by Geography


Cumulative China Yct International Group's Quick Ratio

CYIG's Quick Ratio for the trailling 12 Months

CYIG Quick Ratio

 (Dec 31 2018)
12 Months		 (Sep 30 2018)
12 Months		 (Jun 30 2018)
12 Months		 (Mar 31 2018)
12 Months		 (Dec 31 2017)
12 Months
Y / Y Current Liabilities TTM Growth 9.2 % -5.03 % -15.91 % -12.97 % 41.64 %
Y / Y Cash & cash equivalent TTM Growth 83.93 % 87.72 % 109.24 % 115.37 % 97.34 %
Quick Ratio TTM 16.26 15.72 15.77 13.69 9.65
Total Ranking TTM # 3422 # 3466 # 101 # 133 # 3840
Seq. Current Liabilities TTM Growth 11.7 % 13.43 % 0.23 % -14 % -2.86 %
Seq. Cash & cash equivalent TTM Growth 15.56 % 13.06 % 15.43 % 21.97 % 17.94 %

Quick ratio ranking by company, industry and sector >> Back to CYIG Financial Strength Comparisons >> Go to Compare CYIG Quick Ratio to its Competitors

On the trailing twelve months basis CYIG Cash & cash equivalent soared by 84.34 % in Q3 2018 year on year, faster than Current Liabilities, this led to increase in in China Yct International Group's Quick Ratio to 16.26, above CYIG average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 370 other companies have achieved higher Quick Ratio than China Yct International Group. While Quick Ratio overall ranking has improved so far to 3422, from total ranking during the twelve months ending second quarter 2018 at 3466.

Explain Quick Ratio?
How much Cash & cash equivalents CYIG´s has?
What are CYIG´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 371
Healthcare Sector # 711
Within the Market # 3422


trailing twelve months Quick Ratio Statistics
High Average Low
26.3 13.99 5.05
(Dec 31 2013)   (Jun 30 2016)




Companies with similar Quick Ratio in the quarter ending Dec 31 2018, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2018 MRQ Cash & cash equivalentDec 31 2018 MRQ Current Liabilities
Aratana Therapeutics, Inc.  46.84 $ 42.671  Millions$ 0.911  Millions
Rafael Holdings Inc  45.46 $ 40.504  Millions$ 0.891  Millions
Akero Therapeutics Inc   45.32 $ 75.995  Millions$ 1.677  Millions
Celularity Inc   41.17 $ 0.025  Millions$ 0.001  Millions
Lexaria Bioscience Corp   39.85 $ 1.737  Millions$ 0.044  Millions
Edesa Biotech Inc   39.75 $ 11.044  Millions$ 0.278  Millions
Filana Therapeutics Inc   38.76 $ 19.807  Millions$ 0.511  Millions
Aptinyx Inc   38.41 $ 151.037  Millions$ 3.932  Millions
Viela Bio Inc   37.70 $ 126.898  Millions$ 3.366  Millions
Verrica Pharmaceuticals Inc   36.26 $ 89.809  Millions$ 2.477  Millions
Nexien Biopharma Inc   34.37 $ 0.399  Millions$ 0.012  Millions
Allakos Inc   34.04 $ 178.906  Millions$ 5.256  Millions
Rhythm Pharmaceuticals Inc   33.47 $ 454.580  Millions$ 13.582  Millions
Geron Corporation  33.10 $ 163.558  Millions$ 4.941  Millions
Equillium Inc   32.50 $ 65.913  Millions$ 2.028  Millions
Biospecifics Technologies Corp  32.31 $ 80.884  Millions$ 2.504  Millions
Kezar Life Sciences Inc   32.19 $ 107.432  Millions$ 3.337  Millions
Provention Bio Inc   31.29 $ 58.539  Millions$ 1.871  Millions
Galmed Pharmaceuticals Ltd   31.09 $ 84.132  Millions$ 2.706  Millions
Cymabay Therapeutics Inc   30.66 $ 178.664  Millions$ 5.827  Millions
G1 Therapeutics Inc   29.87 $ 369.290  Millions$ 12.362  Millions
Aravive Inc   29.42 $ 56.992  Millions$ 1.937  Millions
Entasis Therapeutics Holdings Inc   29.38 $ 85.092  Millions$ 2.896  Millions
Xenon Pharmaceuticals Inc   28.96 $ 119.306  Millions$ 4.119  Millions
Spero Therapeutics Inc   28.47 $ 115.443  Millions$ 4.055  Millions
Medicinova Inc   28.43 $ 62.313  Millions$ 2.192  Millions
Cannapowder Inc   28.35 $ 0.714  Millions$ 0.025  Millions
Aprea Therapeutics Inc   27.79 $ 65.676  Millions$ 2.364  Millions
Psyence Biomedical ltd   27.07 $ 0.430  Millions$ 0.016  Millions
Synthorx, Inc.  26.75 $ 188.356  Millions$ 7.042  Millions

Date modified: 2026-09-08T15:09:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.